Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Repeat IV Doses

Summary

GSK2140944 belongs to the Bacterial Type II Topoisomerase Inhibitor (BTI) class of antibiotics. GSK2140944 has demonstrated in vitro and in vivo activity against Gram positive pathogens including methicillin resistant Staphylococcus aureus (MRSA) and Gram-negative pathogens associated with respiratory tract, skin and soft tissue infections including isolates resistant to existing classes of antimicrobials.

Timeline

Start

2012-06-04

Primary completion

2014-02-21

Completion

2014-02-21

Drugs

Indications